Efonidipine is a calcium channel blocker of the dihydropyridine class, commercialized by Shionogi & Co. (Japan). Initially, it was marketed in 1995 under the trade name, Landel. The drug has been shown to block T-type in addition to L-type calcium channels . It has also been studied in atherosclerosis and acute renal failure . This drug is also known as NZ-1...
用于治疗高血压和心绞痛。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.